- Home
- ERII vs SEPN Comparison
ERII vs SEPN Comparison
Compare ERII & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- SEPN
- Stock Information
- Founded
- ERII 1992
- SEPN 2022
- Country
- ERII United States
- SEPN United States
- Employees
- ERII N/A
- SEPN N/A
- Industry
- ERII Industrial Machinery/Components
- SEPN
- Sector
- ERII Technology
- SEPN
- Exchange
- ERII Nasdaq
- SEPN NYSE
- Market Cap
- ERII 848.7M
- SEPN 1.0B
- IPO Year
- ERII 2008
- SEPN 2024
- Fundamental
- Price
- ERII $15.14
- SEPN $24.28
- Analyst Decision
- ERII Strong Buy
- SEPN Strong Buy
- Analyst Count
- ERII 4
- SEPN 4
- Target Price
- ERII $20.75
- SEPN $43.67
- AVG Volume (30 Days)
- ERII 429.3K
- SEPN 464.1K
- Earning Date
- ERII 02-19-2025
- SEPN 02-15-2025
- Dividend Yield
- ERII N/A
- SEPN N/A
- EPS Growth
- ERII 22.95
- SEPN N/A
- EPS
- ERII 0.33
- SEPN N/A
- Revenue
- ERII $135,062,000.00
- SEPN $981,000.00
- Revenue This Year
- ERII $16.43
- SEPN $406.62
- Revenue Next Year
- ERII $11.07
- SEPN N/A
- P/E Ratio
- ERII $45.66
- SEPN N/A
- Revenue Growth
- ERII 19.05
- SEPN N/A
- 52 Week Low
- ERII $12.26
- SEPN $18.62
- 52 Week High
- ERII $20.27
- SEPN $27.47
- Technical
- Relative Strength Index (RSI)
- ERII 36.25
- SEPN N/A
- Support Level
- ERII $15.93
- SEPN N/A
- Resistance Level
- ERII $16.43
- SEPN N/A
- Average True Range (ATR)
- ERII 0.63
- SEPN 0.00
- MACD
- ERII -0.06
- SEPN 0.00
- Stochastic Oscillator
- ERII 8.73
- SEPN 0.00
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.